Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas A Clark

Showing results (41-50 of 85) with videos related to

Pageof 9
Sort By:
Plos One|May 15, 2013
Identifying optimal vaccination strategies for serogroup A Neisseria meningitidis conjugate vaccine in the African meningitis beltSara Tartof, Amanda Cohn, Félix Tarbangdo, et al.
Pharmacoepidemiology and Drug Safety|January 20, 2010
Safety assessment of recalled Haemophilus influenzae type b (Hib) conjugate vaccines--United States, 2007-2008Wan-Ting Huang, Soju Chang, Elaine R Miller, et al.
Pediatrics|August 8, 2012
Haemophilus influenzae type b disease and vaccine booster dose deferral, United States, 1998-2009Elizabeth C Briere, Michael Jackson, Shetul G Shah, et al.
Open Forum Infectious Diseases|September 11, 2015
Population-Based Surveillance of Neisseria meningitidis Antimicrobial Resistance in the United StatesBrian H Harcourt, Raydel D Anderson, Henry M Wu, et al.
BMC Infectious Diseases|August 7, 2013
Phenotypic and genotypic characterization of meningococcal carriage and disease isolates in Burkina Faso after mass vaccination with a serogroup a conjugate vaccinePaul A Kristiansen, Absatou Ky Ba, Idrissa Sanou, et al.
Journal of Clinical Microbiology|October 9, 2004
Epidemiologic and molecular characterization of an outbreak of Candida parapsilosis bloodstream infections in a community hospitalThomas A Clark, Sally A Slavinski, Juliette Morgan, et al.
BMC Infectious Diseases|December 5, 2014
Persistent low carriage of serogroup A Neisseria meningitidis two years after mass vaccination with the meningococcal conjugate vaccine, MenAfriVacPaul A Kristiansen, Absatou Ky Ba, Abdoul-Salam Ouédraogo, et al.
Vaccine|February 1, 2015
Serogroup A meningococcal conjugate (PsA-TT) vaccine coverage and measles vaccine coverage in Burkina Faso--implications for introduction of PsA-TT into the Expanded Programme on ImmunizationSarah A Meyer, Jean Ludovic Kambou, Amanda Cohn, et al.
Journal of Clinical Microbiology|November 6, 2007
Novel Brucella strain (BO1) associated with a prosthetic breast implant infectionBarun K De, Larry Stauffer, Mark S Koylass, et al.
Pediatrics|January 14, 2015
Epidemiology of infant meningococcal disease in the United States, 2006-2012Jessica R MacNeil, Nancy Bennett, Monica M Farley, et al.
Pageof 9

Showing results (41-50 of 85) with videos related to

Sort By:
Pageof 9
Plos One|May 15, 2013
Identifying optimal vaccination strategies for serogroup A Neisseria meningitidis conjugate vaccine in the African meningitis beltSara Tartof, Amanda Cohn, Félix Tarbangdo, et al.
Pharmacoepidemiology and Drug Safety|January 20, 2010
Safety assessment of recalled Haemophilus influenzae type b (Hib) conjugate vaccines--United States, 2007-2008Wan-Ting Huang, Soju Chang, Elaine R Miller, et al.
Pediatrics|August 8, 2012
Haemophilus influenzae type b disease and vaccine booster dose deferral, United States, 1998-2009Elizabeth C Briere, Michael Jackson, Shetul G Shah, et al.
Open Forum Infectious Diseases|September 11, 2015
Population-Based Surveillance of Neisseria meningitidis Antimicrobial Resistance in the United StatesBrian H Harcourt, Raydel D Anderson, Henry M Wu, et al.
BMC Infectious Diseases|August 7, 2013
Phenotypic and genotypic characterization of meningococcal carriage and disease isolates in Burkina Faso after mass vaccination with a serogroup a conjugate vaccinePaul A Kristiansen, Absatou Ky Ba, Idrissa Sanou, et al.
Journal of Clinical Microbiology|October 9, 2004
Epidemiologic and molecular characterization of an outbreak of Candida parapsilosis bloodstream infections in a community hospitalThomas A Clark, Sally A Slavinski, Juliette Morgan, et al.
BMC Infectious Diseases|December 5, 2014
Persistent low carriage of serogroup A Neisseria meningitidis two years after mass vaccination with the meningococcal conjugate vaccine, MenAfriVacPaul A Kristiansen, Absatou Ky Ba, Abdoul-Salam Ouédraogo, et al.
Vaccine|February 1, 2015
Serogroup A meningococcal conjugate (PsA-TT) vaccine coverage and measles vaccine coverage in Burkina Faso--implications for introduction of PsA-TT into the Expanded Programme on ImmunizationSarah A Meyer, Jean Ludovic Kambou, Amanda Cohn, et al.
Journal of Clinical Microbiology|November 6, 2007
Novel Brucella strain (BO1) associated with a prosthetic breast implant infectionBarun K De, Larry Stauffer, Mark S Koylass, et al.
Pediatrics|January 14, 2015
Epidemiology of infant meningococcal disease in the United States, 2006-2012Jessica R MacNeil, Nancy Bennett, Monica M Farley, et al.
Pageof 9